Biotech

• 10/23/2024

  Biotech’s Bright Future: 2024 Outlook and Emerging Trends

• 10/22/2024

  Unraveling the Enigma: Schrödinger, Inc.’s Complex Journey

• 10/20/2024

  Teva Settlement Paves Way for Galafold Revenue Growth

• 10/19/2024

  Wave Life Sciences: AATD Breakthrough Sets Stage for 2025 Catalyst

• 10/19/2024

  Protagonist Therapeutics: Solid Outlook, But Is the Stock Worth It?

• 10/18/2024

  Alzheimer’s Breakthrough: Annovis Bio Advances Clinical Trials

• 10/17/2024

  Arvinas Stock: Will Upcoming Catalyst Overcome Past Volatility?

• 10/9/2024

  **Pfizer Needs a Different Fix**

• 10/8/2024

  **CureVac’s Setback**

• 10/8/2024

  **EGFRm NSCLC Targeting: Q1 2025 Data Update**